Base
NVOCC

ICOS LINE LIMITED

KOWLOON, HONG KONG

Cross-Source Intelligence

Arrivals (12 mo)

0

0 active ports

Active Ports

0

Distinct US ports with vessel activity

Compliance

Clear

6 lists screened

Data compiled from FMC Licensed Carriers & OTIs, OpenSanctions, OFAC SDN, BIS Consolidated Screening List · As of 2026-04-26 · Updates monthly

Sanctions & Compliance Screening

OFAC Specially Designated Nationals (SDN)

No matches found

Search of the OFAC SDN list for “ICOS LINE LIMITED” returned no matches.

BIS Consolidated Screening List (CSL)

No matches found

Search of the BIS CSL for “ICOS LINE LIMITED” returned no matches. This covers the BIS Entity List, Denied Persons List, OFAC SDN, ITAR Debarred, and 10 other U.S. export control lists.

SEC Filings (100)

333-50266
2001-11-09

EX-10.1

View on SEC.gov →
333-50266
2001-02-23

EXHIBIT 10.20

View on SEC.gov →
333-50266
2003-03-28

CONTRACT MANUFACTURING AGREEMENT

View on SEC.gov →
001-37998
2018-11-09

EXHIBIT 99.1

View on SEC.gov →
000-29554
2004-10-28

ICOS Q3-2004 FIGURES

View on SEC.gov →
000-19171
2003-03-13

FORM 10-K FOR FISCAL YEAR ENDED DECEMBER 31, 2002

View on SEC.gov →
000-29554
2004-04-29

ICOS PRESS RELEASE

View on SEC.gov →
000-29554
2005-04-07

FORM 20-F

View on SEC.gov →
000-20117
2002-10-21

TEXAS BIOTECHNOLOGY CORP - OCTOBER 21, 2002

View on SEC.gov →
000-19171
2003-04-30

FORM 10-Q (03-31-03)

View on SEC.gov →
000-29554
2006-04-13

FORM 20-F

View on SEC.gov →
000-29554
2003-04-28

ICOS VISION SYSTEMS FINANCIAL RESULTS FOR FIRST QUARTER OF 2003

View on SEC.gov →
000-19171
2004-03-12

FORM 10-K

View on SEC.gov →
000-19171
2002-11-05

QUARTERLY REPORT FOR PERIOD ENDED 09/30/2002.

View on SEC.gov →
000-29554
2004-04-06

ICOS FORM 20-F

View on SEC.gov →
001-37746
2016-05-31

EX-10.25

View on SEC.gov →
000-20117
2001-05-15

TEXAS BIOTECHNOLOGY CORPORATION - 03/31/2001

View on SEC.gov →
001-15170
2019-09-30

DATA SHOW ANTI-TUMOUR ACTIVITY WITH ICOS AGONIST

View on SEC.gov →
000-29554
2003-06-06

ICOS ANNUAL REPORT ON FORM 20-F

View on SEC.gov →
333-125832
2005-06-15

SEC filing

View on SEC.gov →
000-19171
2002-08-14

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED 6/30/02

View on SEC.gov →
000-29554
2003-07-25

FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2003

View on SEC.gov →
000-20117
2002-05-15

TEXAS BIOTECHNOLOGY CORPORATION - DATED 3/31/2002

View on SEC.gov →
000-29554
2006-04-27

FORM 6-K

View on SEC.gov →
000-20117
2001-08-14

TEXAS BIOTECHNOLOGY CORPORATION - 6/30/01

View on SEC.gov →
000-20117
2002-08-14

TEXAS BIOTECHNOLOGY CORPORATION - DATED 6/30/2002

View on SEC.gov →
000-20117
2003-05-15

TEXAS BIOTECHNOLOGY CORP.- MARCH 31, 2003

View on SEC.gov →
001-06351
2008-04-21

PRESS RELEASE

View on SEC.gov →
000-20117
2003-11-14

ENCYSIVE PHARMACEUTICALS INC.- AMEND.- 03/31/2003

View on SEC.gov →
000-20117
2001-11-14

TEXAS BIOTECHNOLOGY CORPORATION - 9/30/2001

View on SEC.gov →
000-19171
2006-11-02

FORM 10-Q

View on SEC.gov →
000-19171
2004-11-04

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004

View on SEC.gov →
000-19171
2003-11-04

QUARTERLY REPORT PERIOD ENDED SEPTEMBER 30, 2003

View on SEC.gov →
000-19171
2005-03-14

ANNUAL REPORT FOR YEAR ENDED DECEMBER 31, 2004

View on SEC.gov →
000-19171
2003-08-05

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2003

View on SEC.gov →
000-19171
2006-08-03

FORM 10-Q

View on SEC.gov →
000-20117
2002-11-08

TEXAS BIOTECHNOLOGY CORPORATION - DATED 9/30/2002

View on SEC.gov →
000-19171
2001-08-14

DEVELOPMENT & MARKETING AGREEMENT

View on SEC.gov →
000-19171
2004-08-04

FOR THE QUARTER ENDED JUNE 30, 2004

View on SEC.gov →
000-19171
2006-03-08

FORM 10-K

View on SEC.gov →
000-19756
2005-03-16

EX-10.52

View on SEC.gov →
000-19171
2004-05-03

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2004

View on SEC.gov →
000-19171
2006-05-04

FORM 10-Q

View on SEC.gov →
000-19171
2003-03-13

DEFINITIVE SCHEDULE 14A

View on SEC.gov →
000-20117
2003-11-14

ENCYSIVE PHARMACEUTICALS INC.- AMEND.- 12/31/2003

View on SEC.gov →
000-19171
2002-05-14

FORM 10-Q FOR THE PERIOD ENDED 03/31/2002

View on SEC.gov →
000-19171
2002-03-29

FORM 10-K405

View on SEC.gov →
000-20117
2003-03-28

TEXAS BIOTECHNOLOGY CORP.- DECEMBER 31, 2002

View on SEC.gov →
000-19171
2004-03-18

DEFINITIVE PROXY STATEMENT

View on SEC.gov →
000-19171
2005-02-03

CO-PROMOTION AGREEMENT

View on SEC.gov →
000-20117
2003-08-13

ENCYSIVE PHARMACEUTICALS INC. - 6/30/2003

View on SEC.gov →
333-224927
2018-09-07

SEC filing

View on SEC.gov →
000-19756
2003-06-17

EXHIBIT 99.2

View on SEC.gov →
000-20117
2003-11-12

ENCYSIVE PHARMACEUTICALS INC.- SEPTEMBER 30, 2003

View on SEC.gov →
001-16633
2001-09-27

FORM 10-K FOR FISCAL YEAR END JUNE 30, 2001

View on SEC.gov →
000-20117
2003-11-14

ENCYSIVE PHARMACEUTICALS INC.- AMEND.- 06/30/2003

View on SEC.gov →
001-06351
2008-10-23

EX-99.1

View on SEC.gov →
001-37998
2017-03-10

10-K

View on SEC.gov →
001-06351
2008-11-03

FORM 10-Q

View on SEC.gov →
2006-08-07

SEC filing

View on SEC.gov →
000-19171
2001-03-29

FORM 10-K FOR THE FISCAL YEAR ENDED 12/31/2000

View on SEC.gov →
001-06351
2008-05-06

QUARTERLY REPORT

View on SEC.gov →
333-111421
2004-01-30

PROSPECTUS SUPPLEMENT

View on SEC.gov →
000-20117
2001-04-02

TEXAS BIOTECHNOLOGY CORPORATION - 12/31/2000

View on SEC.gov →
333-63790
2001-11-08

PROSPECTUS SUPPLEMENT

View on SEC.gov →
333-63790
2001-11-01

PRELIMINARY PROSPECTUS SUPPLEMENT

View on SEC.gov →
001-06351
2008-10-21

AMENDMENT TO FORM 10-Q

View on SEC.gov →
000-12042
2002-03-29

EX-13 FINANCIAL STATEMENTS FROM 2001 ANNUAL REPORT

View on SEC.gov →
001-06351
2007-05-03

FORM 10-Q

View on SEC.gov →
333-76828
2002-02-13

PROSPECTUS - FILE NO. 333-76828

View on SEC.gov →
000-20117
2002-03-29

TEXAS BIOTECHNOLOGY CORP - YEAR END 12/31/2001

View on SEC.gov →
000-19171
2006-03-16

DEFINITIVE PROXY STATEMENT

View on SEC.gov →
001-16633
2002-09-30

10-K

View on SEC.gov →
333-76828
2002-01-23

AMENDMENT NO. 1 TO FORM S-3

View on SEC.gov →
000-08149
2005-03-15

SEC filing

View on SEC.gov →
333-76828
2002-01-16

FORM S-3

View on SEC.gov →
000-20117
2005-03-09

ENCYSIVE PHARMACEUTICALS INC.- DECEMBER 31, 2004

View on SEC.gov →
811-23325
2024-04-29

CODE OF ETHICS FOR RBC GLOBAL ASSET MANAGEMENT (UK) LIMITED.

View on SEC.gov →
000-19756
2003-06-17

PDF EXHIBIT 99.2

View on SEC.gov →
001-06351
2007-11-05

QUARTERLY REPORT

View on SEC.gov →
811-23309
2024-01-26

EXHIBIT (R)(2)

View on SEC.gov →
377-01199
2016-10-12

SEC filing

View on SEC.gov →
000-31979
2001-05-14

FORM 10-Q FOR QUARTER ENDED MARCH 31, 2001

View on SEC.gov →
000-26483
2010-06-28

EXHIBIT 99.1

View on SEC.gov →
000-49799
2017-10-26

EXHIBIT 99.1

View on SEC.gov →
377-01199
2015-11-06

SEC filing

View on SEC.gov →
377-01199
2016-11-17

SEC filing

View on SEC.gov →
000-19171
2005-03-07

PRELIMINARY PROXY STATEMENT

View on SEC.gov →
333-215372
2017-01-27

424B4

View on SEC.gov →
811-23325
2023-04-28

PERSONAL ACCOUNT DEALING AND PRIVATE INVESTMENT POLICY FOR RBC GLOBAL ASSET MGMT.

View on SEC.gov →
001-06351
2008-02-29

ANNUAL REPORT

View on SEC.gov →
811-23325
2023-04-28

PERSONAL ACCOUNT DEALING AND PRIVATE INVESTMENT POLICY FOR RBC GLOBAL ASSET MGMT.

View on SEC.gov →
2020-06-09

SEC filing

View on SEC.gov →
001-16633
2002-05-13

FORM 10-Q FOR QUARTER ENDED MARCH 31, 2002

View on SEC.gov →
811-23325
2024-04-29

CODE OF ETHICS FOR RBC GLOBAL ASSET MANAGEMENT (UK) LIMITED.

View on SEC.gov →
377-01199
2015-12-11

SEC filing

View on SEC.gov →
333-215372
2016-12-30

S-1

View on SEC.gov →
333-215372
2017-01-17

S-1/A

View on SEC.gov →
001-37746
2016-05-31

EX-10.24

View on SEC.gov →
001-06351
2009-02-27

FORM 10-K

View on SEC.gov →

Source: SEC EDGAR Full-Text Search

Registry Details

FMC OTI Number
027875
License Status
Active
Bond Status
Bonded — AMERICAN ALTERNATIVE INSURANCE CORPORATION
Address
RM 1501, 15TH FL., OMEGA PLAZA, 32-34A DUNDAS STREET, KOWLOON, HONG KONG
Classification
NVOCC

Data Sources

Compliance Screening

No sanctions match

No exact name match found in OpenSanctions global database. This is not a guarantee of compliance — always verify through official channels.

Source: OpenSanctions (OFAC SDN, EU, UN, and 40+ additional lists)

Screening Tools

Search the Consolidated Screening List (BIS, OFAC, DDTC) and global sanctions lists.

Search Screening List
← DICA LOGISTICS LLCALPHA TRANSPORTATION INTERNATIONAL (SHENZHEN) LTD. →